SCHEMBL7152005

SCHEMBL7152005

O=C1Nc2sccc2/C1=C/c1cc2ccccc2[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT1 Q96EB6 1/20 0.57
▸ MAOB P27338 2/20 0.44
▸ CYP2A6 P11509 1/20 0.44
▸ MAP4K1 Q92918 6/20 0.40
▸ KDR P35968 4/20 0.40
▸ PRF1 P14222 1/20 0.39
▸ MAPT P10636 1/20 0.38
▸ IDO1 P14902 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ PDGFRB P09619 1/20 0.38
▸ FGFR1 P11362 1/20 0.38
▸ SRC P12931 1/20 0.38
▸ AMY1A P0DUB6 1/20 0.36
▸ CHEK1 O14757 1/20 0.35
▸ BACE1 P56817 1/20 0.35
▸ SYK P43405 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7152012 1.00 SIRT1 (0.57) SIRT1MAOBCYP2A6MAP4K1KDR
SCHEMBL7152010 1.00 SIRT1 (0.57) SIRT1MAOBCYP2A6MAP4K1KDR
SCHEMBL1538367 0.79 KDR (0.59) SIRT1MAOBMAP4K1KDRMAPT
SCHEMBL2768013 0.79 KDR (0.59) SIRT1MAOBMAP4K1KDRMAPT
SCHEMBL14712887 0.75 SIRT1 (0.69) SIRT1MAOBCYP2A6PRF1MAPT
SCHEMBL6627549 0.74 PDPK1 (0.58) KDRPDGFRBFGFR1CHEK1SYK
SCHEMBL6627542 0.74 PDPK1 (0.58) KDRPDGFRBFGFR1CHEK1SYK
SCHEMBL6627546 0.74 PDPK1 (0.58) KDRPDGFRBFGFR1CHEK1SYK
SCHEMBL6389287 0.73 LRRK2 (0.62) SIRT1MAP4K1IDO1PDGFRB
SCHEMBL6390272 0.73 RET (0.62) SIRT1MAOBMAP4K1KDRPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6528653-B2 E.g., 4,6-dihydro 4-(heterocyclic ring-methylene)thieno(2,3-b) pyrrolidin-5-one derivatives; tumor necrosis factor ) inhibitors; anticarcinogenic, -proliferative and -arthritic agents; Alzheimer's disease; cardiovascular disorders HOFFMANN-LA ROCHE, INC. 2003-03-04 — — US disclosed
Send feedback